For eczema, PRP may suppress IL-31 (itch-related) and IL-1β (neuro-sensitization -related) (13, 30–32) through the action of its released or activated endogenous anti-inflammatory factors, such as TGF-β1 and IL-10 (40). Here, IL1B is linked to Eczematoid dermatitis.